Portfolio company
Cartiva
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company manufactures synthetic cartilage implants for surgeons to treat patients with big toe osteoarthritis and other musculoskeletal joint conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Hyalex Orthopaedics
This company develops synthetic cartilage and implant systems to restore damaged joint surfaces for patients with osteoarthritis or cartilage injuries.
Hyalex
This company develops synthetic cartilage products and implant systems to restore damaged joint surfaces for patients with joint injuries or osteoarthritis.
CartiHeal
This company develops aragonite-based implants for the regeneration of cartilage and bone in patients with traumatic or osteoarthritic joint defects.
OrthoPreserve
This company develops synthetic meniscus implants for patients with knee injuries to restore joint function and prevent the development of arthritis.
Altach Biomedical
This company develops biomimetic collagen scaffolds to regenerate damaged joint cartilage for patients with musculoskeletal injuries and osteoarthritis.
Atro Medical
This company develops synthetic meniscus prostheses to restore knee function and relieve pain for patients with chronic knee injuries.
Bioventus
Bioventus develops and manufactures orthobiologic products, including bone healing devices and joint pain injections, for orthopaedic surgeons and musculoskeletal care settings.
Moximed
This company develops implantable shock absorbers for patients with knee osteoarthritis to reduce joint load and delay the need for replacement surgery.